SLX4IP and breast carcinoma: However, this result has been debated as Robinson et al. showed that the loss of SLX4IP in U2OS or murine breast cancer D2.OR cells decreased the frequency of ALT markers, suggesting that SLX4IP stimulates ALT (Robinson et al., 2020).